Exploring how COVID-19 affects children's reading skills
Official title: Assessing the links between risk factors, COVID-19 impacts, and reading skills
Funded at Florida State University · NIH-10892980 · Data updated 2026-11-12
This study looks at how the COVID-19 pandemic has affected kids' reading skills, especially those between 0 and 11 years old, to find out which children might need extra help with their learning.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Florida State University NIH-funded |
| Lab location | 1 site (Tallahassee, United States) |
| Project start | August 12, 2022 |
| Project end | July 31, 2027 |
| Funding year | 2024 |
| Award (this year) | $595,803 |
| NIH project number | 5R01HD109292-03 |
| Project ID | NIH-10892980 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research include children aged 0-11 years who have experienced disruptions in their education due to COVID-19.
✕Less likely to help
Children who have not been affected by COVID-19-related educational disruptions may not benefit from this research.
What this research studies
This research investigates the impact of the COVID-19 pandemic on children's reading abilities, particularly focusing on children aged 0-11 years. It aims to understand how various risk factors and the stressors brought on by the pandemic have influenced academic outcomes, especially in reading. By utilizing a risk-resilience model, the study will analyze data from a national twin project to uncover the short-term and long-term effects of COVID-19 on reading skills. The findings could help identify children who are most at risk and inform interventions to support their learning.
Why it matters
Potential benefit: If successful, this research could lead to targeted strategies to improve reading skills in children affected by the pandemic.
How similar studies have gone: Previous research has shown that understanding the impacts of educational disruptions can lead to effective interventions, suggesting this approach has potential for success.
Where this research is happening
-
Florida State University
Tallahassee, United States Active
Researchers
- Principal investigator: Little, Callie — Florida State University
- Study coordinator: Little, Callie
Related research
Other NIH-funded projects on the same topics.
-
Blocking a blood-vessel protein to protect the brain after COVID-19
Researchers are testing whether a drug that blocks the alpha5beta1 integrin can protect the brain and reduce memory and thinking problems after COVID-19 or in people with vascular dementia.
-
Investigating how COVID-19 affects people with sickle cell disease
This study is looking at how COVID-19 affects people with sickle cell disease, especially among African Americans, to better understand the risks and long-term symptoms they might face.
-
Investigating how the respiratory microbiome affects COVID-19 severity in older adults
This study is looking at how the germs in our lungs might affect how seriously older adults get sick from COVID-19, by checking samples from over 200 hospitalized patients to see if certain germs are linked to worse outcomes, especially for those with other health issues.
-
Identifying risk factors for heart problems in COVID-19 patients
This study is looking at what makes some people more likely to have heart problems after being hospitalized with COVID-19, so we can better understand their needs and improve their care.
-
Identifying risk factors for severe COVID-19-related inflammatory syndrome in children
This study is looking at what makes some kids more likely to get sick with Multisystem Inflammatory Syndrome after having COVID-19, so we can find ways to help those who might need extra care.
-
Exploring how a specific protein affects cognitive issues related to COVID-19 in older adults
This study is looking at how COVID-19 might lead to memory and thinking problems in older adults with vascular dementia, and it will test if a special treatment can help improve their brain function by blocking a specific protein.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.